On Feb 19, 2026, ICUI reported earnings of 1.91 USD per share (EPS) for Q4 25, beating the estimate of 1.72 USD, resulting in a 10.68% surprise. Revenue reached 535.94 million, compared to an expected 541.25 million, with a -0.98% difference. The market reacted with a +4.87% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of 1.79 USD, with revenue projected to reach 532.75 million USD, implying an decrease of -6.28% EPS, and decrease of -0.60% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.07
Actual
-$0.66
Surprise
-1005.35%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.01
Surprise
-149.02%
FAQ
What were ICU Medical Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, ICU Medical Inc reported EPS of $1.91, beating estimates by 10.68%, and revenue of $535.94M, -0.98% below expectations.
How did the market react to ICU Medical Inc's Q4 2025 earnings?
The stock price moved up 4.87%, changed from $149.74 before the earnings release to $157.03 the day after.
When is ICU Medical Inc expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for ICU Medical Inc's next earnings report?
Based on 5
analysts, ICU Medical Inc is expected to report EPS of $1.79 and revenue of $532.75M for Q1 2026.